Skip to main navigation Skip to search Skip to main content

SARS-CoV-2 Infection and Childhood Islet Autoimmunity

Research output: Contribution to journalLetterpeer-review

Abstract

Increased incidence of type 1 diabetes (T1D) has been observed during the COVID-19 pandemic.1 In children who were genetically at risk, SARS-CoV-2 infection was associated with increased risk of islet autoimmunity (IA) in some longitudinal cohorts2 but not others.3 Additionally, COVID-19 may accelerate progression to clinical T1D in children with IA.4 We investigated the potential temporal association between SARS-CoV-2 infection and the development of IA in the longitudinal Australian Environmental Determinants of Islet Autoimmunity (ENDIA) study.
Original languageEnglish
Pages (from-to)568-570
Number of pages3
JournalJAMA Pediatrics
Volume179
Issue number5
Early online date3 Mar 2025
DOIs
Publication statusPublished - 5 May 2025

Funding

FundersFunder number
NHMRC National Health and Medical Research Council 1025083, 2026105, 2021404, 2032781

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'SARS-CoV-2 Infection and Childhood Islet Autoimmunity'. Together they form a unique fingerprint.

    Cite this